In addition, some of the modulated proteins found in the present study such as haptoglobin or S100A4 have been related to CMT or human breast cancer previously, which confirms the validity of our study design for CMT evaluation and the use of CMT as a model for breast cancer research. The gene discussed is S100A4; the disease is breast cancer.